stockrow
Friday 6 November 2026
Export OPTH’s income statement to Excel — free account
Optimi Health Corp.
OPTH Healthcare Drug Manufacturers Specialty & Generic
Optimi Health Corp.’s revenue for fiscal 2025 (year ended September 2025) was $304,800.00, up 6.39% from fiscal 2024.
2.30
0.09
−3.77%
Follow OPTH
Alert me
| Sep '24 | Jun '25 | Dec '25 | Mar '26 | |
|---|---|---|---|---|
ROIC |
0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
0.00% | 0.00% | 0.00% | 0.00% |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
— | 0.00 | 0.00 | (1.52) |
Free Cash Flow |
— | — | — | (4.89) |
Capital Expenditures |
— | — | — | (0.13) |
| Other line items | ||||
Cash ROIC |
0.00% | 0.00% | 0.00% | (92.72%) |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
— | — | — | 0.00 |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.17 |
Capex/Depreciation |
— | — | — | (0.09) |
Revenue per Share |
— | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
— | 0.00 | 0.00 | (1.48) |
Capex per Share |
— | 0.00 | 0.00 | (0.04) |
Capex to Sales |
— | — | — | 0.00 |
Columns are period end dates · fundamentals updated 2 Nov 2026